From the Third Department of Internal Medicine, Nagasaki University School of Medicine, 7-1 Sakamoto-machi, Nagasaki City 852, Japan.
*To whom reprints should be addressed .
III is the des-aspartic acid derivative of angiotensin II. Its plasma concentration has been measured of human1) and experimental animals.
2) The main biological actions of AIII are thought to be vasoconstriction, stimulation of aldosterone secretion, and suppression of renin release in experimental animals.3),4) In addition the biological actions of AIII in normal human subjects have been evaluated by Kono et al5) and Carey et al.6) However, the action of AIII in essential hypertension (EH) has not been reported. The present study was carried out to evaluate the effect of AIII on reninangiotensin-aldosterone system in EH. 
SUBJECTS AND METHODS

RESULTS
Blood pressure changes: Two examples of blood pressure changes are shown in Fig. 1 . The upper panel shows the blood pressure changes during AIII administration in a patient with low-renin EH. The blood pressure rose from 172/98mmHg to 212/114mmHg after administration of AIII for 10min. After stopping the administration of AIII, the blood pressure returned to the previous level in 4min. This patient showed marked elevation of blood pressure by AIII. The lower panel shows the blood pressure changes during AIII infusion in a patient with renovascular hypertension. This patient had an elevated PRA (8.0ng/ml/hr at rest) and showed no elevation of blood pressure after AIII administration.
The blood pressure changes during AIII administration in tionship between AIII induced changes in PRA, PAC, and blood pressure is shown in Fig. 8 . There were no significant relationships between changes of PRA and PAC, PRA and blood pressure.
DISCUSSION
Recent reports suggest that AIII is found in human plasma and that it may have an important role in the control of aldosterone secretion. Semple and Morton1) reported that AIII in normal human plasma was about 12% of the total peptides which react with an antibody to All. It has been proposed that two different pathways may produce AIII. The first pathway is a conversion from angiotensin I via AII and the second pathway is a conversion from angiotensin I via des-aspartic acid angiotensin I.7) Campbell et al8) and Vaugham et al9) have shown that this 2nd pathway exists in rats. It 
